Plexpress

High-content gene expression analysis

PlexPress provides a high-content gene expression analysis platform to support gene function analysis. This platform can be used, for example, in developing safer and more effective drugs.

PlexPress uses TRAC (Transcriptional Analysis with the aid of affinity Capture) technology to monitor gene samples. TRAC makes it possible to multiplex 10–60 genes and monitor them in anything between 10 to 1000 samples. The large number of genes and samples monitored enables a higher throughput screening (HTS) than any of the competitors’ products do.

The TRAC technology reduces the time needed to generate reliable data, effectively bringing the related costs down.

Investors

VTT Ventures OyConor Technology Fund I KyAloitusrahasto Vera Oy,
Helsingin Yliopiston rahasto, Management

Additional Information

CEO Juhana Rauramo
+358 40 504 0355
juhana.rauramo(at)plexpressbio.com
plexpressbio.com

  • Contact Us

    Erkki Aaltonen
    Investment Director
    +358 400 736 783
  • Entrepreneur-in-Residence
  • VTT Ventures Ltd

    VTT Ventures Ltd.’s mission is to focus on extracting value from VTT technology in developing VTT based high-tech companies with international growth potential.